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Abstract. Chronic post-traumatic osteomyelitis (OM) 
represents a particular challenge for nuclear medicine 
and radiology since clinical and biochemical parameters 
are frequently unreliable. The aim of this study was to 
investigate the value of combined bone scan (BS) and 
immunoscintigraphy (IS) with technetium-99m labelled 
monoclonal antigranulocyte antibody (MAB) in patients 
with suspected chronic OM of the appendicular skeleton. 
Twenty-four patients (17 females and 7 males) with sus- 
pected chronic post-traumatic OM were evaluated with 
three-phase BS/99mTc-MAB-IS. The final diagnosis was 
established by means of bone culture and histology in 19 
cases and clinical follow-up in five cases. The studies 
were reviewed by two independent and experienced ob- 
servers; the interobserver agreement was calculated by 
kappa statistics. The sensitivity, specificity and accuracy 
of BS alone were 92%, 18% and 58%, respectively. 
Combined BS/99mTc-MAB-IS had a sensitivity, specific- 
ity and accuracy of 84%, 72% and 79%, respectively. Of 
24 studies, 11 were true-positive, two false-negative, 
eight true-negative and three false-positive. Two patients 
presented with unexpected ectopic haematopoietic bone 
marrow in the appendicular skeleton that caused false- 
positive results. A high degree of interobserver agree- 
ment was found (~:=0.85). It is concluded that combined 
BS/99mTc-MAB-IS represents a very sensitive and repro- 
ducible method with an acceptable specificity for the in- 
vestigation of chronic OM. Problems may occur in the 
differentiation f low-grade OM from aseptic inflamma- 
tion. Another problem is ectopic marrow that may occur 
in the appendicular skeleton due to a chronic inflamma- 
tory stimulus. A former intramedullary intervention i  
the femur with displacement of haematopoietic marrow 
may also lead to an ectopic location. 
Correspondence to: A. Kaim, Institute of Nuclear Medicine, Uni- 
versity Hospital Basel, Petersgraben 4, CH-4032 Basel, Switzer- 
land 
Eur J Nucl Med (1997) 24:732-738 
Introduction 
Chronic post-traumatic and postoperative osteomyelitis 
represents a disabling disease that requires a detailed in- 
vestigation for assessment of active infection and local 
extent in order to decide upon the appropriate therapeu- 
tic management. Beside radiological methods [X-ray 
plain film, computed tomography (CT), magnetic reso- 
nance imaging (MRI)], nuclear medicine offers a wide 
variety of radiopharmaceuticals for the imaging of in- 
flammation or infection, e.g. gallium-67 citrate [1, 2], 
technetium-99m labelled nanocolloids [3], 99mTc-la- 
belled human immunoglobulins [4-6], indium-111 oxine 
and 99mTc-hexamethylpropylene amine oxime 
(HMPAO)-labelled autologous leucocytes [7-11]. 99mTc- 
labelled monoclonal antigranulocyte antibody (MAB) 
immunoscintigraphy (IS) represents a simple, practica- 
ble and specific method that has been extensively stud- 
ied for the detection of inflammatory and septic process- 
es. Extra-osseous infection [12, 13], acute and subacute 
osteomyelitis [14-16], spondylodiscitis [6, 14] and in- 
fection of hip arthoplasties [ 12, 13, 16, 17] have been the 
main subjects of these publications. Until now no study 
has specifically considered the value of IS in chronic re- 
current or low-grade osteomyelitis of the appendicular 
skeleton. Therefore, the accuracy of IS with MAB as an 
adjunct to bone scan in the evaluation of this rare but im- 
portant patient group was assessed. 
Materials and methods 
Patients Twenty-four patients (17 males and 7 females; mean age 
47 years, range 21-83 years) referred to the Nuclear Medicine de- 
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partraent with suspected bone infection were examined with bone 
scan and IS. Only patients with suspected chronic osteomyelitis of
the appendicular skeleton were included. Arthroplasties of the hip 
were not considered. One or more of the following criteria was 
present: clinical signs (swelling, heat, redness, fistula), pain, fever, 
elevated laboratory parameters (ESR, CRP, WBC count) and sus- 
pected focal infection on radiology (X-ray plain film, CT, MRI). 
All patients suffered from longstanding, post-traumatic chronic 
osteomyelitis; the mean interval from first surgery to the present 
study was 8.6 years (range 2 months to 42 years). The average 
number of operations due to recurrent osteomyelitis was four 
(range 1-15), and the interval from last surgery to the present av- 
eraged 3.5 years (2 months to 42 years). Six patients had ortho- 
paedic devices (metal plate, intramedullary nail, external fixator). 
The suspected areas were investigated by X-ray plain films in all 
patients, by CT in 11 patients and by MRI in nine patients. Final 
diagnosis was established by surgery with microbiological nd/or 
histological analysis in 19 patients and by clinical course over a 
period of at least 6 months in five patients. Radiological results 
were considered in defining the final diagnosis. 
Radiopharmaceuticals The antigranulocyte antibody used for IS is 
a murine monoclonal antibody (BW250/183), supplied by Beh- 
ringwerke AG, Switzerland. The antibody is an immunoglobulin 
of the IgG isotype and binds to the epitope NCA 95 on the surface 
of human granulocytes. The antibody is reduced with stannous II- 
chloride solution and labelled with 99mTc. After an incubation pe- 
riod of 10 min, 555 MBq of the antibody solution (equivalent to 
0.5 mg of the antibody) was intravenously injected into the pa- 
tient. Serum was obtained before and 3 weeks after injection to 
determine the titre of human antimouse antibodies (HAMA). 
None of the patients developed HAMA, and no side-effects or ad- 
verse reactions were observed. 
For 99mTc-diphosphonate bone scan, 3,3-diphosphono-l,2-pro- 
panedicarboxyl acid tetrasodium salt (DPD) (Hoechst, Switzer- 
land) was used. It was labelled with an average of 740 MBq of 
99mTc" 
Imaging modalities All patients first underwent quantitative three- 
phase bone scan followed by IS at an interval of 2 days to 1 week. 
After injection of 99mTc-DPD 20 5-s images were immediately 
registered and another 60-s image was taken at 5 min. Five hun- 
dred-kcount planar spot images were obtained 3 h after injection 
and stored on computer using a 256x256 matrix. 
IS was performed 17 h p.i. Planar spot images of the suspected 
area in at least two projections were obtained. Five hundred- 
kcount images with a 256x256 matrix were recorded. Additional- 
ly whole-body images were obtained. Imaging was performed 
with a Siemens DIACAM gamma camera equipped with a low-en- 
ergy high-resolution (LEHR) collimator connected to a dedicated 
computer system (Icon, Siemens). 
Data interpretation Bone scans and IS were reviewed by two ex- 
perienced observers (A, B) unaware of the definitive diagnosis. 
The readers were independent of each other and interpreted the 
studies separately. X-ray plain films were used to identify the 
Fig. la-e.  True-positive result in a patient with infected pseudarthrosis and bone necrosis 3 years after trauma. Plate osteosynthesis had 
been performed 1 year prior to the current investigation, a Radiograph (anteroposterior) shows pseudarthrosis of the tibial diaphysis, b
Late bone scan (anterior) shows hyperactivity of the complete tibia with a photopenic zone at the site of pseudarthrosis suggesting bone 
necrosis (black arrow), e Intense accumulation of 99mTc-MAB on IS (anterior) demonstrating the extent of the infection 
European Journal of Nuclear Medicine Vol. 24, No. 7, July 1997 
734 
anatomy. The degree of agreement between the two observers was 
measured by kappa statistics [18] calculating the index ~: (~: is 0.0 
when there is just a chance agreement and 1.0 when there is per- 
fect agreement). Two of 26 studies were interpreted ifferently 
and had to be discussed with a third observer (C). After analysing 
these cases, agreement was achieved among all three observers 
and the final scintigraphic diagnosis was established. These data 
were the basis for calculating sensitivity, specificity and accuracy. 
IS was considered positive when accumulation was observed 
in comparison to background and the contralateral side. Uptake 
was graded as absent, mild or strong. Normal late bone scan and 
positive IS were interpreted as indicating soft tissue infection. Os- 
teomyelitis was diagnosed if bone scan and IS were positive at the 
same anatomical location. Infected necrotic bone was considered 
in zones of decreased bone metabolism with positive IS. 
Results 
Twenty-four patients with suspected osteomyelitis were 
examined. Thirteen patients presented with active osteo- 
myelitis, four had soft tissue infections and in the re- 
maining seven surgery, histology, cultures radiology 
and/or clinical course failed to reveal evidence of infec- 
tion. Of the 24 suspected lesions, 15 were located in the 
tibia, eight in the distal femur and one in the diaphysis 
of the humerus. Laboratory results (ESR, CRR WBC 
count) showed elevated levels in six patients with active 
osteomyelitis, in four patients with soft tissue infection 
and in one patient without infection. The remaining pa- 
tients (seven with osteomyelitis, six without osteomyeli- 
tis) had normal laboratory results. In 9/13 patients the 
causative micro-organism was Staphylococcus aureus, in 
3/13 patients coagulase-negative Staphylococcus and in 
1/13 patients diagnosis was confirmed by histology 
without microbiology. Delayed bone scan (3 h) revealed 
increase bone metabolism in 21/24 cases. In 3/21 cases 
areas of photopenia occurred beside zones of  increased 
tracer activity corresponding to necrotic bone. Consider- 
ing the bone scan alone, sensitivity, specificity and accu- 
racy were calculated to be 92%, 18% and 58%, respec- 
tively. Combined bone scan and IS had a sensitivity, 
Fig. 2a-d. False-positive finding in a 66-year-old patient 
with a fracture of the femoral diaphysis 34 years previous- 
ly. History of recurrent chronic osteomyelitis and repeated 
surgery, the last intervention being 7 months ago (intra- 
medullary reaming), a Radiographs (anteroposterior and 
lateral) of the femoral diaphysis hows post-traumatic 
changes with a laminated appearance of the cortical bone 
and periosteal bone formation. They are no evident signs 
of infection, b Late bone scan (anterior) reveals increased 
bone metabolism of the complete femoral diaphysis, c Im- 
munoscintigraphy (anterior) demonstrates accumulation 
of 99mTc-MAB in the middle of the femoral diaphysis 
along the periosteal and cortical bone with sparing of the 
medullary cavity (black arrowheads), d Histological over- 
view shows subperiosteal cortical bone with a laminated 
appearance and interspersed haematopoietic and fatty 
marrow (arrows). Arrowheads: periosteum 
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No. Sex Age Interval No. of Interval Laboratory Anatomical Bone IS Final diagnosis Method of 
(yrs) from operations from last parameters site Scan diagnosis 
1 st surgery surgery verification 
1 f 65 4 months 1 4 months 1" Humerus + ++ OM (Staph. Surgery TP 
aureus) 
2 f 83 8 months 3 4 months Normal Distal femur ++ ++ OM (coag. neg. Surgery TP 
Staph.) 
3 f 21 3 years 1 3 years Normal Distal femur ++ 0 OM Surgery/ FN 
histology 
4 m 74 4 months 1 4 months $ Distal femur ++ 0 No infection Surgery TN 
5 f 27 10 years 3 8 years Normal Tibia ++ ++ No infection Surgery/ FP 
histology 
6 m 76 25 years 7 3 years Normal Tibia ++ + OM (Staph. Surgery TP 
aureus, E. coli) 
7 m 65 9 years 15 2 years 1" Tibia 0 ++ Soft tissue Clinical TN 
infection course, MRI 
8 m 66 34 years 5 7 months Normal Femur ++ ++ No infection Surgery/ FP 
histology 
9 m 40 3 years 5 2 years Normal Tibia ++ ++ OM (Staph. Surgery TP 
aureus) 
10 m 49 3 years 3 1 year Normal Tibia + + OM (Staph. Surgery TP 
alAreblS) 
11 m 59 1.5 years 2 6 months Normal Distal femur + 0 No infection Clinical TN 
course 
12 m 43 1.5 years 4 1 year I" Tibia ++ ++ OM (Staph. Surgery TP 
aureus) 
13 m 35 5 years 3 2 years $ Tibia 0 ++ Soft tissue Clinical TN 
infection course 
14 f 21 2 months 1 2 months 1" Tibia ++ ++ Soft tissue Surgery TN 
infection 
15 f 58 42 years 1 42 years 1" Tibia + 0 No infection Surgery TN 
16 m 42 17 years 5 8 years $ Tibia ++ + OM (Staph. Surgery TP 
abtYeblS) 
17 m 42 5 months 1 5 months Normal Tibia ++ ++ OM (coag. neg. Surgery TP 
Staph. ) 
18 m 39 8 months 1 8 months 1" Tibia 0 0 OM (Staph. Surgery FN 
aureus) 
19 m 35 10 years 5 2 years Normal Tibia + 0 No infection Clinical TN 
course 
20 m 45 25 years 4 1 year Normal Tibia ++ + OM (coag. neg. Surgery TP 
Staph.) 
21 m 42 1.5 years 3 7 months Normal Distal femur ++ ++ Soft tissue Surgery/ FP 
infection histology 
22 f 25 3 years 1 3 years $ Distal femur ++ ++ OM (Staph. Surgery TP 
aureus 
23 m 27 2 years 3 1.5 years "]" Distal femur ++ + OM (Staph. Surgery TP 
aureus) 
24 m 37 10 years 8 I year Normal Tibia + 0 No infection Clinical TN 
course 
0, No uptake; +, mild uptake;++, strong uptake; TP, true-positive; FN, false-negtive; TN, true-negative; FR false-positive 
speci f ic i ty and accuracy o f  84%, 72% and 79%, respec-  
tively. O f  the 24 studies, 11 were  t rue-pos i t ive (TP) and 
eight, t rue-negat ive (TN).  The sc int igraphic  pattern that 
occurred in act ive osteomyel i t i s  with in fected pseudar-  
throsis and necrot ic  bone is demonst rated  in Fig. 1. Two 
studies were fa lse-negat ive (FN) and three, fa lse-pos i t ive 
(FP). F igure  2 i l lustrates an FP  f inding that is d iscussed 
later. 
There  was a strong agreement  between the two ob- 
servers A and B. The l~-value for interobserver  agree- 
ment  was 0.85 (95% conf idence  interval  0 .74-0 .99) .  
The individual  patient data are summar ized in Table 1. 
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Discussion 
The diagnosis of chronic complicated osteomyelitis rep- 
resents a particular challenge for radiology and nuclear 
medicine. Low-grade and recurrent longstanding infec- 
tion may cause chronic pain, fistulae and bone necrosis 
with pathological fracture. The disease may lead to dis- 
ability and impair quality of life in a young patient pop- 
ulation. Frequently clinical and biochemical parameters 
are inadequate for making the diagnosis. Our series con- 
firms that laboratory parameters are inconclusive in the 
evaluation of chronic osteomyelitis. The assessment of
disease activity, disease xtension and the separation of 
bony from soft tissue infection influence the therapeutic 
management by the referring surgeon. Nuclear medicine 
offers very useful information in the investigation of 
bone infection. 99mTc-diphosphonate bone scan repre- 
sents the basic study and is very sensitive in detecting 
bone alterations. However, it is unable to distinguish be- 
tween infection and aseptic post-traumatic changes; 
thus, we calculated a specificity of 18%. Diphosphonate 
scan has to be followed by inflammatory scintigraphy, 
and radiolabelled autologous leucocyte scintigraphy and 
99mTc-labelled MAB-IS are specific for the detection of 
infected foci. The clinical use of these methods is pre- 
dominantly determined by their potential availability and 
their practicability in routine clinical practice. Radiola- 
belled autologous white cells are still considered the 
gold standard in the nuclear imaging of infected sites. 
However, the examination requires time-consuming ex
vivo blood handling techniques and special training, and 
entails risk of infection for both laboratory personal and 
patients. 
99mTc-MAB binding granulocytes show a quite similar 
in vivo distribution to that of radiolabelled granulocytes 
and allow the detection of granulocyte accumulation i
the appendicular skeleton [19, 20]. The advantage of 
99mTc-MAB is the simplicity of the labelling process of 
Tc with the antibodies and the in vivo labelling of granu- 
locytes. The antibodies are directed against he myeloid- 
specific surface antigen NCA-95 expressed by granulocy- 
tes. A disadvantage of MAB is the induction of HAMA in 
3%, which can lead to altered biodistribution [21, 22]. Al- 
lergic reactions or serious adverse reactions have not been 
reported so far. Problems in the detection of infection ap- 
pear in areas of active bone marrow such as the spine, the 
pelvis and the proximal femora because precursor cells of 
the granulopoietic system such as promyelocytes are also 
labelled. A physiological uptake in the bone marrow oc- 
curs and infection causes non-specific photopenic zones 
due to bone marrow destruction. All patients included in 
our study had suspected infections in the appendicular 
skeleton. Chronic infection of the pelvis and spine were 
excluded, as was hip prosthesis infection. Sensitivity, 
specificity and accuracy for proven infection were calcu- 
lated to be 84%, 72% and 79% respectively. 
Currently there are four published series with small 
numbers of patients reporting the use of 99mTc-MAB in 
chronic osteomyelitis [6, 14-16]. The reported sensitivi- 
ty (79%-100%) and specificity (64%-100%) show a 
wide range due to the different inclusion criteria for 
chronic osteomyelitis. A major part of the reported ata 
has been based on patient groups with acute and sub- 
acute infections [6, 14, 15]. Furthermore, patients with 
septic hip arthroplasties [15] and even chronic infection 
of the axial skeleton [6, 14] have been included. We con- 
sidered only patients with suspicion of infection of the 
tubular bones at least 6 weeks after surgery or trauma, 
with the majority of patients having suffered from long- 
standing recurrent osteomyelitis. We therefore believe 
that the results of our study accurately reflect he ability 
to image infection with MAB in chronic post-traumatic 
osteomyelitis. The published studies reporting the use of 
99mTc-HMPAO-labelled leucocytes for the detection of 
chronic osteomyelitis calculated values for sensitivity 
(83%-93%) and specificitiy (78%-100%) that suggest 
superiority over IS [7, 10, 23, 24]. Until now, however, 
no comparative study that proves this hypothesis has 
been performed in this field of application. 
There are several possible reasons for false-negative 
studies. One is technical problems uch as incomplete 
labelling of the MAB. In follow-up studies there may be 
induction of HAMA that have the potential to intercept 
the antibody and therefore hinder specific accumulation 
at infection sites [22]. In our study no HAMA response 
was observed and the laboratory titre controls were nor- 
mal. Another potential explanation is the inaccessibility 
of the infection site due to encapsulation. I  osteomyeli- 
tis after intramedullary nailing an avascular zone in the 
central part of the diaphysis occurs due to hyperthermic 
injury and may be infected [25]. This infection between 
the nail and cortical bone may be encapsulated and 
thereby prevent the migration of the radiolabelled MAB- 
binding granulocytes. One of our two false-negative 
studies is explained by this phenomenon. A further pos- 
sible reason for equivocal findings is a small number of 
granulocytes atthe infected site in chronic low-grade os- 
teomyelitis. The histology of one patient with positive 
microbiology for infection revealed a chronic inflamma- 
tion with predominantly l mphocytes and plasma cells 
and only some scattered granulocytes. IS did not show 
significant tracer accumulation a d the study was finally 
considered to be false-negative. 
On the other hand, non-purulent inflammation may 
sometimes include some polymorphonuclear cells which 
lead to a mild uptake on IS and cannot be distinguished 
from low-grade osteomyelitis. False-positive scans have 
been described in fractures, osteosarcoma, eosinophilic 
granuloma, Paget's disease and granulation tissue of all 
kinds [14, 26]. Sometimes it is very difficult to deter- 
mine whether infection is in bone or soft tissue. In one 
false-positive case, planar scintigraphy performed in two 
projections had been positive in bone scan and IS. Exact 
anatomical localization was impossible and the examina- 
tions were interpreted as positive for osteomyelitis. Sur- 
gery revealed a soft tissue infection without osseous in- 
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volvement. Increased bone metabolism may be ex- 
plained by the postoperative state and sometimes an 
overlying positive IS is of uncertain significance. This 
may lead to misinterpretation, and careful analysis of 
scintiscans and X-ray plain films for anatomical land- 
marks is necessary. In doubtful cases, single-photon 
emission tomography may be indicated. 
Two patients presented with unexpected ectopic ac- 
tive bone marrow in the appendicular skeleton that gave 
rise to false-positive studies. In both cases histology re- 
vealed haematopoietically active bone marrow at the 
suspected locations. No histological signs of infection 
were found and microbiology was negative. The strongly 
positive IS was explained by the labelling of the 
promyelocytes with the 99mTc-MAB. One of the two pa- 
tients had a 10-year history of recurrent post-traumatic 
osteomyelitis of the tibial diaphysis with repeated surgi- 
cal procedures. The reason for this unexpected finding 
remains unclear. It is possible that various mediators 
such as cytokines, macrophage colony stimulating fac- 
tor, granulocyte colony stimulating factor or bone mor- 
phogenetic protein [27-29] are released by stromal ele- 
ments due to a chronic inflammatory stimulus and in- 
duce neogenesis of active bone marrow in the peripheral 
skeleton. Until now, however, there have been no reports 
of such a phenomenon, and further investigations are re- 
quired. The other patient had a 34-year history of chron- 
ic osteomyelitis at the femoral middiaphysis that had 
been treated several times by medullary nailing or intra- 
medullary reaming. Histology revealed islands of hae- 
matopoietically active bone marrow arranged in layers 
between the architecture of the remodelled cortical bone. 
One possible explanation for this case is that active bone 
marrow had been displaced from the proximal femur to 
the diaphyseal location during the intramedullary surgi- 
cal procedures and integrated into cortical bone in the 
course of endosteal remodelling. 
Two studies were differently interpreted by the two 
observers (A, B) and definitive diagnosis was estab- 
lished after discussion with a third observer. Both cases 
had been interpreted as negative by one observer due to 
mild radionuclide accumulation on IS which was 
thought to demonstrate a non-purulent inflammation. 
Considering the results of all examinations, however, a 
high degree of agreement was found between observer 
A and B 0¢:-0.85), proving IS with MAB to be a repro- 
ducible method for the recognition of chronic osteomy- 
elitis. 
Two recently published reports have presented en- 
couraging results using a 99mTc-antigranulocyte mono- 
clonal antibody fragment [10, 24]. The advantages over 
MAB are the shortened imaging time and a negligible 
HAMA response rate. The sensitivity, specificity and ac- 
curacy were comparable or even superior to those ob- 
tained with ~1 lin_oxin e or 99mTc-HMPAO labelled white 
blood cells. Further studies to assess the clinical value of 
this imaging method in chronic osteomyelitis are being 
planned. 
In conclusion, this study confirms that IS is a very 
sensitive, accurate and reproducible method for evaluat- 
ing chronic complicated osteomyelitis. We found the 
specificity to be only 18% with bone scan alone whereas 
combined bone scan and IS yielded a specificity of 72%. 
One major problem is the differentiation between low- 
grade infection and aseptic inflammation; a further prob- 
lem derives from the ectopic active bone marrow that 
may occur in the appendicular skeleton due to chronic 
inflammation or former surgical procedures, resulting in 
false-positive studies, hnage interpretation should be 
performed with X-ray plain film since disturbed postop- 
erative anatomy may exist, and one should be aware of 
the patient's history and former surgical procedures. The 
majority of patients represent complicated cases with 
limitations on activities of daily life. Therefore preopera- 
tive assessment u ilizing the modern imaging modalities 
of nuclear medicine (bone scan, IS) and radiology (CT, 
MRI) is required, with the modalities being used in a 
complementary fashion. 
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